Bilan e-santé OK, et toi ? – Le Monde
Health Online 2013: Survey Results

Take #2: Big Pharma Opt for New Strategy to Emerging Markets | eyeforpharma

Despite the many obstacles that remain, it is clear why Big Pharma is stepping up – and continuing – its efforts in the emerging markets. By 2015, sales in these countries are expected to account for 28% of global pharmaceuticals spending, while the US and Europe are set to continue to shrink.

See on